A phase II trial to assess the activity and tolerability of Thymosin alpha 1 in Cystic Fibrosis Patients
Latest Information Update: 31 Aug 2021
At a glance
- Drugs Thymalfasin (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors SciClone Pharmaceuticals
- 31 Aug 2021 New trial record